5.94

0.83% -0.05

Pre-market: 5.92 -0.02 -0.34%

Armata Pharmaceuticals Inc (ARMP)

Overview News Price History Option Chain Discussions Forecast Stock Split

Armata Pharmaceuticals Inc stock is traded at $5.94, with a volume of 69,749. It is down -0.83% in the last 24 hours and up +22.73% over the past month. Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections in the United States. The company develops its products using its proprietary bacteriophage-based technology. Its product candidate is the AP-SA01 that targets Staphylococcus aureus, including multidrug-resistant strains. The company is also developing and advancing synthetic phage for treating diseases caused by pseudomonas aeruginosa. Armata Pharmaceuticals, Inc. is headquartered in Marina del Rey, California.

Previous Close:

$5.99

Open:

$5.65

24h Volume:

69,749

Relative Volume:

0.26

Market Cap:

$216.26M

Revenue:

Net Income/Loss:

$-41.36M

P/E Ratio:

-3.622

EPS:

-1.64

Net Cash Flow:

$-42.09M

1W Performance:

-17.73%

1M Performance:

+22.73%

6M Performance:

+200.76%

1Y Performance:

+176.28%

1-Day Range:

$5.5239

$5.9748

1-Week Range:

$5.21

$7.38

52-Week Range:

$0.8981

$16.34

Armata Pharmaceuticals Inc Stock (ARMP) Company Profile

Name

Armata Pharmaceuticals Inc

Sector

Healthcare (1131)

Industry

Biotechnology (632)

Phone

310-655-2928

Address

4503 Glencoe Avenue, Marina del Rey, CA

Employee

Twitter

Next Earnings Date

2025-03-19

Latest SEC Filings

ARMP's Discussions on Twitter

Compare ARMP with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ARMP Armata Pharmaceuticals Inc	5.94	218.08M	0	-41.36M	-42.09M	-1.64
VRTX Vertex Pharmaceuticals Inc	457.26	117.50B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	722.83	76.06B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	464.56	62.53B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	916.31	56.75B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	205.04	44.10B	447.02M	-1.18B	-906.14M	-6.1812

Armata Pharmaceuticals Inc Stock (ARMP) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-19-19	Initiated	Ladenburg Thalmann	Buy

Armata Pharmaceuticals Inc Stock (ARMP) Latest News

03:08 AM

Is Armata Pharmaceuticals Inc. (TG1N) stock testing key supportJuly 2025 Pullbacks & Verified Momentum Stock Watchlist - Newser

03:08 AM

01:54 AM

Why Armata Pharmaceuticals Inc. (TG1N) stock attracts HNW investorsPortfolio Growth Summary & Weekly Top Gainers Trade List - Newser

01:54 AM

Dec 04, 2025

Will Armata Pharmaceuticals Inc. stock announce special dividendBull Run & Real-Time Chart Breakout Alerts - Newser

Dec 04, 2025

Why Armata Pharmaceuticals Inc. stock is a strong buy call2025 Trade Ideas & Consistent Growth Equity Picks - Newser

Dec 04, 2025

Will Armata Pharmaceuticals Inc. stock split attract more investorsJuly 2025 Patterns & Weekly Top Stock Performers List - Newser

Dec 04, 2025

What is the fair value estimate for Armata Pharmaceuticals Inc. stock in 2025CPI Data & Long-Term Growth Plans - Newser

Dec 04, 2025

Will Armata Pharmaceuticals Inc. (TG1N) stock extend growth storyEarnings Risk Summary & Long-Term Safe Return Strategies - Newser

Dec 04, 2025

How Armata Pharmaceuticals Inc. (TG1N) stock compares with market leadersJuly 2025 Outlook & AI Powered Trade Plan Recommendations - Newser

Dec 04, 2025

Is Armata Pharmaceuticals Inc. stock considered safe havenMarket Movement Recap & Accurate Entry and Exit Point Alerts - Newser

Dec 04, 2025

Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Shares Up 12.8%Still a Buy? - MarketBeat

Dec 04, 2025

Dec 03, 2025

Market Catalysts: Can Armata Pharmaceuticals Inc. stock deliver surprise earnings beatJuly 2025 Snapshot & Safe Entry Trade Reports - BỘ NỘI VỤ

Dec 03, 2025

Will Armata Pharmaceuticals Inc. (TG1N) stock see insider accumulationQuarterly Portfolio Report & Smart Swing Trading Techniques - Newser

Dec 03, 2025

How risky is Armata Pharmaceuticals Inc. stock compared to peers2025 Trade Ideas & Real-Time Volume Analysis Alerts - Newser

Dec 03, 2025

Will Armata Pharmaceuticals Inc. (TG1N) stock sustain dividend payoutsWeekly Trend Report & AI Based Trade Execution Alerts - Newser

Dec 03, 2025

Is Armata Pharmaceuticals Inc. (TG1N) stock among top earnings playsEarnings Risk Report & Fast Momentum Entry Tips - Newser

Dec 03, 2025

Dec 02, 2025

How Armata Pharmaceuticals Inc. (TG1N) stock performs during market turbulenceJuly 2025 Gainers & Safe Capital Growth Stock Tips - Newser

Dec 02, 2025

Why analysts recommend Armata Pharmaceuticals Inc. stockDividend Hike & Daily Entry Point Trade Alerts - Newser

Dec 02, 2025

Is Armata Pharmaceuticals Inc. stock a buy before earnings resultsAnalyst Downgrade & Weekly Watchlist for Hot Stocks - Newser

Dec 02, 2025

Dec 01, 2025

Armata Pharmaceuticals Enters Capital Sales Agreement - TipRanks

Dec 01, 2025

Nov 29, 2025

Will Armata Pharmaceuticals Inc. stock pay special dividendsJuly 2025 Volume & Risk Adjusted Buy and Sell Alerts - BỘ NỘI VỤ

Nov 29, 2025

Armata Pharmaceuticals to Present Late-Breaking Clinical Data highlighting its Staphylococcus aureus Bacteriophage Cocktail, AP-SA02, at IDWeek 2025™ (PR Newswire) - Aktiellt

Nov 29, 2025

Nov 27, 2025

New Highs: Why Armata Pharmaceuticals Inc. stock attracts global investorsMarket Growth Review & Weekly Consistent Profit Watchlists - BỘ NỘI VỤ

Nov 27, 2025

Nov 26, 2025

Armata Pharmaceuticals Announces Second Quarter 2025 Results and Provides Corporate Update (PR Newswire) - Aktiellt

Nov 26, 2025

Nov 21, 2025

Comparing Armata Pharmaceuticals Inc. in custom built stock radarsCEO Change & AI Forecasted Entry/Exit Points - newser.com

Nov 21, 2025

Can Armata Pharmaceuticals Inc. (TG1N) stock attract ESG investmentsMarket Risk Summary & Technical Buy Zone Confirmations - newser.com

Nov 21, 2025

Is Haria Apparels Limited Stock Risky in the Current Market EnvironmentLow Beta Stocks & Fast Growing Capital Gains - earlytimes.in

Nov 21, 2025

Nov 20, 2025